Sienna Rights Issue Closing 9th January 2017
23-Dec-2016 Sienna Cancer Diagnostics Limited advises that the closing date for the
current Rights Issue offer to shareholders is 9 January 2017.
The Rights Issue is being undertaken on the basis of 1 new share for
every 4.26 ordinary shares held by eligible shareholders on the record date (17
November 2016), at an issue price of $0.17 per ordinary share. For every
three (3) new ordinary shares subscribed for, one (1) option will be granted,
exercisable at $0.22. These options vest on 2 April 2018 and remain
exercisable for 6 months.
The company is pleased with the response to the Rights Issue to date,
and reserves the right to place any shortfall.